In the present study, we found that the major urinary metabolite of aldosterone, tetrahydroaldosterone, quantified in 24 h urines by a sensitive and specific GC–MS assay [24] is positively associated with FGF23 concentrations in plasma of kidney stone formers. This evidence concerns the gene FGF23 and nephrolithiasis.